MYLK and breast cancer: In total, nine genes including ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), BOC (BOC cell adhesion associated, oncogene regulated), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), FGF7 (fibroblast growth factor 7), KCNK3 (potassium two pore domain channel subfamily K member 3), MAP1A (microtubule associated protein 1A), MYLK (myosin light chain kinase), PPARGC1A (PPARG coactivator 1 alpha), and REEP2 (receptor accessory protein 2) were determined to be associated with OS (Figure 2) and DFS (Figure S5) of BC patients.